Skip to content
Lower risk Medical device recall · FDA · Published June 2, 2025

EMPOWR 3D Knee Insert Recall: Incorrect Product Risk

Encore Medical recalls EMPOWR 3D knee tibial inserts due to packaging errors that may lead to incorrect product selection and revision surgery.

🇺🇸 FDA recall #Z-2126-2025Medical deviceEncore Medical ›
Take action

Contact the company

Recalling firmEncore Medical, LP9800 Metric Blvd · Austin, TX 78758-5445
✎ GovInfoNow plain-language explainer

Encore Medical is recalling EMPOWR 3D knee tibial inserts that may be packaged with the wrong components. Using these could lead to needing revision surgery if the incorrect product is selected. Read more at govinfonow.com/recall/52165-empowr-3d-knee-insert-recall-incorrect-product-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/52165-empowr-3d-knee-insert-recall-incorrect-product-risk · Updated August 18, 2026 · FDA enforcement record: FDA #Z-2126-2025

Cite this page

“EMPOWR 3D Knee Insert Recall: Incorrect Product Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/52165-empowr-3d-knee-insert-recall-incorrect-product-risk. Based on FDA recall #Z-2126-2025 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2126-2025%22&limit=1).

Encore Medical, LP recalled the EMPOWR 3D KNEE TIBIAL INSERT - E-PLUS due to a packaging discrepancy that may result in incorrect implants being selected. The Food and Drug Administration announced the voluntary Class II recall on June 2, 2025.

How to tell if you have it

  • Brand: Encore Medical
  • Product Name: EMPOWR 3D KNEETM INS, 11L 12MM, VE
  • Model/Catalog Number: 341-12-711
  • UPC: 00888912166980
  • Lot Code: 115T1077

The hazard

The recall is due to a packaging discrepancy with incorrect tibial inserts being packaged. The use of this product may result in the incorrect product being selected, which could result in a revision surgery if used.

Context

GovInfoNow's records show Encore Medical, LP has 43 other recalls on record since May 31, 2017. Recent similar recalls include an EMPOWR 3D KNEE Ins 11L 14MM VE packaging mix-up (Feb. 16, 2026) and an EMPOWR 3D KNEE Implants incorrect labeling notice (Jan. 15, 2026). Other recent recalls of similar products include a U2 Total Knee System Femoral Offset Bushing recall (March 19, 2026), a Howmedica TRIATHLON Hinge Insert recall (July 30, 2026), and a U2 Total Knee System Femoral Valgus Adaptor recall (May 20, 2026).

How to tell if you have this one

Check for the model number 341-12-711 on the packaging. The product was sold with lot code 115T1077 and software version NA.

  • Brand
    Encore Medical
  • Product
    Brand Name: EMPOWR 3D KNEE TIBIAL INSERT - E-PLUS Product Name: EMPOWR 3D KNEETM INS, 11L 12MM, VE Model/Catalog
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    U.S Distribution to states of: AZ, IA, ID, IL, IN, LA, MI, MO, MS, NE, NY, OK, OR, PR, SD, UT, VA, and WA
Recall numberProduct, codes & lots
Z-2125-2025Brand Name: EMPOWR 3D KNEE TIBIAL INSERT - E-PLUS Product Name: EMPOWR 3D KNEETM INS, 11L 10MM, VE Model/Catalog Number: 341-10-711 Software Version: NA Product Description: Enovis" knee devices are intended for treatment of patients who are candidates for knee arthroplasty per the Indication for use. While total knee replacements are not intended to withstand activity levels and loads of normal healthy bone, they are a means of restoring mobility and reducing pain for many patients. Component: NA; Lot Code: Item: 341-10-711 GTIN: 00888912166881 Lot\s: 071T1084
Z-2126-2025Brand Name: EMPOWR 3D KNEE TIBIAL INSERT - E-PLUS Product Name: EMPOWR 3D KNEETM INS, 11L 12MM, VE Model/Catalog Number: 341-12-711 Software Version: NA Product Description: Enovis" knee devices are intended for treatment of patients who are candidates for knee arthroplasty per the Indication for use. While total knee replacements are not intended to withstand activity levels and loads of normal healthy bone, they are a means of restoring mobility and reducing pain for many patients. Component: NA; Lot Code: Item: 341-12-711 GTIN: 00888912166980 Lot: 115T1077
Based on the official FDA remedy

What to do — step by step

  1. Check Product Packaging

    Look for the model number 341-12-711 and lot code 115T1077 on the packaging to confirm if it's the recalled item.

Where it went and when

Where it was distributed

Distributed in 17 states and Puerto Rico.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: yesWAIdaho: yesIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: yesILWisconsin: not listedWIMichigan: yesMINew York: yesNYRhode Island: not listedRIMassachusetts: not listedMAOregon: yesORNevada: not listedNVWyoming: not listedWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: yesUTColorado: not listedCONebraska: yesNEMissouri: yesMOKentucky: not listedKYWest Virginia: not listedWVVirginia: yesVAMaryland: not listedMDDelaware: not listedDEArizona: yesAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFLPuerto Rico: yesPR

FDA distribution: “U.S Distribution to states of: AZ, IA, ID, IL, IN, LA, MI, MO, MS, NE, NY, OK, OR, PR, SD, UT, VA, and WA” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Arizona, Idaho, Illinois, Indiana, Iowa, Louisiana, Michigan, Mississippi, Missouri, Nebraska, New York, Oklahoma, Oregon, Puerto Rico, South Dakota, Utah, Virginia, Washington.

Recall timeline

FDA published this recall 51 days after the firm started it.

1. Firm started the recall: Jun 2, 202512. FDA classified it Class II: Jul 17, 202523. Published in FDA’s Enforcement Report: Jul 23, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2126-2025 (June 2, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2126-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA